# Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

> **NCT03065907** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 3 (actual)

## Conditions studied

- Low Vision
- Neovascular Age-related Macular Degeneration

## Interventions

- **OTHER:** Vision rehabilitation

## Key facts

- **NCT ID:** NCT03065907
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2018-09-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03065907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03065907, "Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03065907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*